The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
benzyl N-[(2S)-1-(4-{2-[(naphthalen-1-yl)formamido]acetyl}piperazin-1-yl)-1-oxo-6-(prop-2-enamido)hexan-2-yl]carbamate ID: ALA5276449
Chembl Id: CHEMBL5276449
Max Phase: Preclinical
Molecular Formula: C34H39N5O6
Molecular Weight: 613.72
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCN(C(=O)CNC(=O)c2cccc3ccccc23)CC1
Standard InChI: InChI=1S/C34H39N5O6/c1-2-30(40)35-18-9-8-17-29(37-34(44)45-24-25-11-4-3-5-12-25)33(43)39-21-19-38(20-22-39)31(41)23-36-32(42)28-16-10-14-26-13-6-7-15-27(26)28/h2-7,10-16,29H,1,8-9,17-24H2,(H,35,40)(H,36,42)(H,37,44)/t29-/m0/s1
Standard InChI Key: RHJAGJUKRBNEDR-LJAQVGFWSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 613.72Molecular Weight (Monoisotopic): 613.2900AlogP: 3.01#Rotatable Bonds: 13Polar Surface Area: 137.15Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.53CX Basic pKa: ┄CX LogP: 2.48CX LogD: 2.48Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.20Np Likeness Score: -0.80
References 1. Cundy NJ, Arciszewski J, Gates EWJ, Acton SL, Passley KD, Awoonor-Williams E, Boyd EK, Xu N, Pierson É, Fernandez-Ansieta C, Albert MR, McNeil NMR, Adhikary G, Eckert RL, Keillor JW.. (2023) Novel irreversible peptidic inhibitors of transglutaminase 2., 14 (2.0): [PMID:36846375 ] [10.1039/d2md00417h ]